GLP-1 Weight-Loss Clinic in Coquitlam
A locally dispensed weight-management program for patients in the Tri-Cities and Lower Mainland. Pharmacist-led intake, prescriber consultation, and direct dispensing from our Coquitlam pharmacy. No shipping, no national mail-order.
Five things a national mail-order pharmacy cannot offer
Online prescribing platforms have made GLP-1 medications easier to access, but they still ship a temperature-sensitive injectable from a distant warehouse. Mediglen is a community pharmacy on The High Street in Coquitlam. Here is what that means for patients in the Tri-Cities and Lower Mainland.
There is no separate visit fee at Mediglen. The pharmacist review is free, the consultation with the prescribing doctor is billed to MSP, and you pay only for the medication itself. Many national online platforms charge $40 to $99 for the visit alone.
In-pharmacy injection support
Every patient receives in-person injection training from a Mediglen pharmacist before their first dose. Patients who prefer not to self-inject can have their weekly injection administered at the pharmacy at no additional cost.
Cold-chain integrity, no shipping
GLP-1 injectables are biologic medications that must be kept cold. Mediglen does not ship to patients. Medication moves directly from our pharmacy fridge to your home by local delivery, or you pick up in person.
Direct insurance billing
If you have private drug coverage, we bill your insurer directly, and you pay only the difference. Our pharmacy team also prepares and submits prior-authorization paperwork when your plan requires it.
Same-day pickup, next-day delivery
Once your prescription arrives at Mediglen, you can pick up the same day during business hours or receive complimentary local delivery in the Tri-Cities, typically the next business day.
Free medication review by a pharmacist
Every intake includes a PharmaNet pre-screen by a Mediglen pharmacist. We pull your full medication history and check for interactions with the proposed GLP-1 therapy before the prescriber ever sees your file.
Who can be considered for a GLP-1 prescription
Eligibility is determined by a Canadian-licensed prescriber after reviewing your intake form, pharmacist pre-screen, and medical history. The criteria below reflect the typical clinical thresholds used in British Columbia. Final decisions are always made by the prescriber based on your individual circumstances.
Typically considered when
- You are 18 years of age or older
- BMI is 30 or higher (obesity), or BMI is 27 or higher with a weight-related medical condition such as type 2 diabetes, hypertension, dyslipidemia, or sleep apnea
- You have made earlier lifestyle attempts at weight management (the prescriber will discuss this)
- You do not have any of the contraindications listed in the opposite column
- You are willing to engage with the dose-titration schedule for your specific medication
Not appropriate when
- Personal history of medullary thyroid carcinoma (MTC)
- Family history of MTC or Multiple Endocrine Neoplasia type 2 (MEN 2)
- Prior pancreatitis
- Currently pregnant, planning pregnancy, or breastfeeding
- Active eating disorder
- Severe gastroparesis or other significant gastrointestinal motility disorder
- Currently taking another GLP-1 medication
- Known hypersensitivity to the proposed medication
This is general information only. The prescriber will review the full Health Canada product monograph criteria during your consultation.
How it works, from intake to first dose
The whole process is designed to be efficient without skipping the clinical steps that matter. Most patients move from intake form to first prescription within one to two weeks, depending on whether baseline bloodwork is needed.
You complete the intake form
About 10 to 15 minutes online. Covers your medical history, current medications, and weight-loss goals.
Pharmacist reviews your file
A Mediglen pharmacist pulls your PharmaNet history, checks for interactions, and may order baseline bloodwork if needed.
Prescriber consultation
Your file goes to a Canadian-licensed prescriber, either online through Avee or in person at the medical clinic next door, for clinical review and a consultation.
Prescription to Mediglen
If a GLP-1 is appropriate for you, the prescription is sent directly to our pharmacy. We confirm your coverage and prepare your order.
Pickup or local delivery
Same-day pickup at our Coquitlam pharmacy, or next-day local delivery in the Tri-Cities. Free injection training included.
The medications Mediglen dispenses
All medications below are authorized by Health Canada and supplied by their original manufacturers. Click any medication to see available doses, the typical titration schedule, and current Mediglen cash pricing. Insurance billing is processed separately. See the Pricing section below.
About this medication
Ozempic is a once-weekly subcutaneous injection of semaglutide, a GLP-1 receptor agonist. It is authorized by Health Canada for the treatment of adults with type 2 diabetes mellitus to improve glycemic control. It is sometimes prescribed off-label for weight management; eligibility for any use is determined by your prescriber.
Doses and Mediglen cash pricing
| Dose / Pen | Duration per pen | Mediglen price |
|---|---|---|
| Brand Ozempic, 0.25 / 0.5 mg pen (2 mg total) | ~4 weeks (starter, includes titration) | $130 |
| Brand Ozempic, 1 mg pen (4 mg total) | ~4 weeks (maintenance) | $130 |
| Generic semaglutide, either pen formatGeneric | ~4 weeks | $110 |
Generic semaglutide contains the same active ingredient as Ozempic, in the same once-weekly pen formats, and carries the same Health Canada indication for type 2 diabetes. Mediglen dispenses Health Canada-authorized generic semaglutide at $110 per pen, alongside brand Ozempic at $130 per pen. Additional generic versions are expected as more manufacturers receive Health Canada authorization. If your prescriber writes for semaglutide, our pharmacist can confirm whether the brand or a generic is dispensed.
Typical titration schedule
Doses are stepped up gradually to minimize gastrointestinal side effects. Your prescriber will adjust the schedule for your individual response. In Canada, the maximum authorized Ozempic dose is 1 mg weekly.
About this medication
Wegovy is once-weekly semaglutide authorized by Health Canada as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity.
Doses and Mediglen cash pricing
| Dose / Pen | Duration per pen | Mediglen price |
|---|---|---|
| 0.25 mg pen | ~4 weeks (week 1 to 4) | $360 |
| 0.5 mg pen | ~4 weeks (week 5 to 8) | $360 |
| 1.0 mg pen | ~4 weeks (week 9 to 12) | $360 |
| 1.7 mg pen | ~4 weeks (week 13 to 16) | $360 |
| 2.4 mg pen (maintenance) | ~4 weeks (week 17+) | $360 |
All doses are the same price.
Typical titration schedule
Each step is held for approximately 4 weeks before increasing.
About this medication
Mounjaro is a once-weekly injection of tirzepatide, a dual GIP and GLP-1 receptor agonist. It is authorized by Health Canada for the treatment of adults with type 2 diabetes mellitus to improve glycemic control. The dual mechanism is associated with substantial weight reduction in clinical trials.
Doses and Mediglen cash pricing
| Dose | Duration per pen | Mediglen price |
|---|---|---|
| 2.5 mg pen (starter) | ~4 weeks | $341 |
| 5 mg pen | ~4 weeks | $341 |
| 7.5 mg pen | ~4 weeks | $418 |
| 10 mg pen | ~4 weeks | $418 |
| 12.5 mg pen | ~4 weeks | $510 |
| 15 mg pen (max) | ~4 weeks | $510 |
Typical titration schedule
About this medication
Zepbound is tirzepatide indicated specifically for chronic weight management as an adjunct to a reduced-calorie diet and increased physical activity in adults with obesity, or overweight with at least one weight-related comorbidity. Same active ingredient as Mounjaro, different Health Canada indication.
Doses and Mediglen cash pricing
| Dose | Duration per pen | Mediglen price |
|---|---|---|
| 2.5 mg pen (starter) | ~4 weeks | $341 |
| 5 mg pen | ~4 weeks | $341 |
| 7.5 mg pen | ~4 weeks | $418 |
| 10 mg pen | ~4 weeks | $418 |
| 12.5 mg pen | ~4 weeks | $510 |
| 15 mg pen (max) | ~4 weeks | $510 |
Typical titration schedule
About this medication
Saxenda is a once-daily subcutaneous injection of liraglutide, authorized by Health Canada for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity. Saxenda has been on the market longer than the weekly GLP-1s, with extensive long-term safety data.
Doses and Mediglen cash pricing
| Dose | Duration per pack | Mediglen price |
|---|---|---|
| 3.0 mg/day (maintenance) | ~1 month (multi-dose pen pack) | $518 |
Typical titration schedule
Daily dose increases weekly until maintenance dose is reached or the highest tolerable dose is achieved.
About this medication
Rybelsus is the only oral GLP-1 medication currently available in Canada. It is once-daily oral semaglutide authorized by Health Canada for type 2 diabetes. Important: it must be taken on an empty stomach with a small amount of plain water (no other food or drink for at least 30 minutes after). Suitable for patients who cannot or prefer not to inject.
Doses and Mediglen cash pricing
| Strength | Pack size | Mediglen price |
|---|---|---|
| 3 mg tablets (starter) | 30-day pack | $291 |
| 7 mg tablets | 30-day pack | $291 |
| 14 mg tablets (max) | 30-day pack | $291 |
All doses are the same price.
Typical titration schedule
About this medication
Contrave is not a GLP-1. It is a fixed-dose combination of naltrexone (an opioid receptor antagonist) and bupropion (a norepinephrine-dopamine reuptake inhibitor), authorized by Health Canada for chronic weight management. It works through different mechanisms than the GLP-1 medications listed above and may be considered for patients for whom a GLP-1 is unsuitable, ineffective, or unaffordable.
Doses and Mediglen cash pricing
| Item | Quantity | Mediglen price |
|---|---|---|
| 8 mg naltrexone / 90 mg bupropion (extended release) | 120 tablets (~30 days at maintenance dose) | $365 cash |
| Same medication, with manufacturer discount card | 120 tablets | $220 with card |
Ask our pharmacist about the manufacturer discount card. We can provide one at the pharmacy.
Typical titration schedule
Stepped up over 4 weeks from one tablet daily to the maintenance dose of two tablets twice daily.
Product images are courtesy of the respective manufacturers' media kits and are shown for identification purposes only. Display of a product image does not imply manufacturer endorsement, partnership, or affiliation with Mediglen Pharmacy.
What it actually costs
Mediglen displays cash prices for every medication and dose above. If you have private drug coverage, we bill your insurer directly, and you pay only the difference. Generic semaglutide is now authorized in Canada. Mediglen dispenses generic semaglutide at $110 per pen and brand Ozempic at $130 per pen.
What you pay for at Mediglen
Full cost breakdown, with no hidden fees.
| Online intake form | $0 |
| Pharmacist review of your file and PharmaNet history | $0 |
| Pharmacist-ordered baseline bloodwork, if needed | $0* |
| Prescriber consultation | $0* |
| Injection training and weekly in-pharmacy injection | $0 |
| Local delivery in the Tri-Cities | $0 |
| The medication itself | Variable |
Direct insurance billing
If you have private drug coverage (employer plan, individual plan, Pacific Blue Cross, Sun Life, Manulife, Canada Life, Green Shield, and most others), Mediglen submits your claim directly. You pay only the portion not covered by your plan.
Our pharmacy team also handles prior-authorization paperwork when your plan requires it. Bring your drug plan card or send the details to us in advance, and we will confirm your coverage before dispensing.
BC PharmaCare and special coverage
BC PharmaCare coverage for weight-management GLP-1 medications has historically been limited and is subject to change. Some products may be covered under specific authority criteria. Mediglen's pharmacy team can check your current PharmaCare status and walk you through the documentation required for any available coverage pathway. Verify before launch
The same active ingredient, in the same once-weekly pens. Two price points.
What to expect, and what to watch for
GLP-1 medications are well-studied and have an established safety profile in clinical practice, but they are not without side effects. The information below is general; your prescriber will discuss your individual risk profile during the consultation.
Common side effects
Usually mild to moderate, most common during dose increases, and tend to improve over several weeks as the body adjusts.
- Nausea (most common, often improves within days to weeks)
- Decreased appetite (expected and clinically intended)
- Constipation
- Diarrhea
- Reflux or heartburn
- Fatigue during dose increases
- Injection-site reactions (mild redness or itching)
Less common, more serious
These are rare but worth knowing. Contact your prescriber or the pharmacy if you experience any of the following.
- Severe, persistent abdominal pain (possible pancreatitis)
- Sudden right-upper-quadrant abdominal pain (possible gallbladder issue)
- Severe persistent nausea or vomiting
- Signs of allergic reaction (rash, swelling, breathing difficulty)
- Vision changes (in patients with diabetic retinopathy)
- Hypoglycemia (in patients also taking insulin or sulfonylureas)
- Lump or swelling in the neck, persistent hoarseness
⚠ Why Mediglen does not dispense compounded semaglutide
Mediglen Pharmacy dispenses only Health Canada-authorized, manufacturer-supplied GLP-1 medications. Health Canada has issued warnings about compounded GLP-1 products, citing safety, sterility, and the use of unauthorized salt forms. While compounded versions are sometimes promoted at lower prices, the clinical evidence base, dose accuracy, and quality controls that apply to the manufacturer products do not apply to them. We believe this policy is in our patients' best interest.
References & further reading
- Health Canada: GLP-1 receptor agonists product information
- STEP trial program (semaglutide for weight management)
- SURMOUNT trial program (tirzepatide for weight management)
- SCALE trial program (liraglutide for weight management)
- College of Pharmacists of BC: Virtual care standards (proposed bylaw)
- Obesity Canada: Clinical Practice Guidelines
Common questions, answered
Quick answers to the questions Mediglen pharmacists hear most often from patients considering a GLP-1 weight-loss program.
Your information is secure
Mediglen Pharmacy is licensed by the College of Pharmacists of British Columbia. Patient information is handled under federal and provincial privacy law and stored on Canadian infrastructure.
Health information handled under PIPEDA, BC PIPA, and CPBC standards
All intake form submissions are encrypted in transit and at rest, stored on Canadian infrastructure, and accessed only by the Mediglen pharmacy team and the reviewing prescriber.
This page is reviewed by Mediglen pharmacists
Page content reviewed on 13 May 2026. Reviewed for clinical accuracy, current Health Canada authorization status, and consistency with the College of Pharmacists of British Columbia practice standards.
Ready to begin?
The intake form takes 10 to 15 minutes. A Mediglen pharmacist will review it within one to two business days and walk you through next steps.